Investing.com -- Hims & Hers Health shares climbed as much as 7.2% in premarket trading on Thursday, following a 10% rally on Wednesday. The stock is set to extend its advance for a fourth straight ...

Two healthcare names are drawing fresh analyst attention this week as Wall Street recalibrates around a landmark GLP-1 truce ...

Hims & Hers Health, Inc.'s revenue is projected to reach $2.7B in 2026 & $3.2B in 2027, implying less than 2x forward sales. Read more on HIMS stock here.

Yahoo Finance anchor Josh Lipton tracks Wednesday's top moving stocks and biggest market stories in this Market Minute. Hims ...

Hims & Hers extended its winning streak to a third consecutive day on Wednesday, jumping 10.27 percent to close at $25.88 apiece, as investors resumed buying positions after a series of analyst ...

Consumers are paying in cash in a hotly competitive marketplace, creating a rare phenomenon for a relatively new class of prescription drugs: falling prices.

Ten stocks boasted strong gains on Wednesday amid a lackluster wider market, thanks to a flurry of corporate developments including partnerships, product launches, and analyst upgrades, among others.

The panel is scheduled to meet on March 18 and 19, but the meeting could be postponed if a federal judge sides with medical groups suing the Trump administration over its sweeping changes to vaccine ...

Up Another 13% 4 hours ago Live Shares of HIMS are up another 13%, or by $3.10, on news that Novo Nordisk agreed to distribute its products through the Hims platform, ending a longstanding feud ...

Artificial intelligence cloud provider Nebius Group (NBIS) is trending on Thursday, after shares jumped following the announcement that chipmaker Nvidia (NVDA) will invest $2bn (£1.49bn) in the ...

Hims & Hers Health Inc NVO shares are higher Wednesday morning after a series of announcements this week reinforced investor optimism around the company's weight-loss strategy and broader platform ...

If you're looking for the most hated stocks on Wall Street, start with this list. All seven companies are worth more than $1 billion but have more than 30% of their available shares held by short ...